Pacira BioSciences, Inc. (NASDAQ:PCRX) Receives Consensus Recommendation of "Hold" from Brokerages
Brokerages have issued a consensus "Hold" rating for Pacira BioSciences (NASDAQ:PCRX), with an average 12-month price target of $29.80 against its current price of $23.00. The company recently surpassed quarterly earnings estimates, reporting $0.73 EPS on $192.4 million in revenue. Institutional investors hold a …